Clinical Trial Update: Evaluate the Safety & Assess Local and Systemic PK of DS003 Vaginal Tablets Administered to Healthy HIV-negative Women [Phase 1]

View source ↗

Summary

Phase 1 trial updates safety and pharmacokinetics of DS003 vaginal tablets in healthy HIV-negative women; study status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• DS003 vaginal tablets (DS003)

Snippet

Sponsor: International Partnership for Microbicides, Inc. | Conditions: HIV | Phase 1 | Status: COMPLETED